Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate plus alfentanil versus propofol for general anesthesia in obese surgical patients
ChiCTR2500104019Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and propofol in obesity (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Incidence of adverse events during induction. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
remimazolamalfentanilpropofol
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2500104019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104019.